STERIS plc (STE) stock forecast and price target
Price $264.32 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($264.32)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends March 31, 2027 | $11.44 | +12.5% | $6.4B |
| Next fiscal year ends March 31, 2028 | $12.46 | +8.8% | $6.8B |
| Next quarter ends December 31, 2026 | $2.79 | +10.3% | $1.6B |
| Quarter after ends March 31, 2027 | $3.14 | +11.0% | $1.7B |
Consensus of the analysts covering STERIS, updated daily. In the last 30 days 7 estimates were raised and 0 lowered.
Our model vs. Wall Street
Analysts see 6.4% upside over 12 months. Our discounted cash flow model with moderate assumptions puts STERIS’s intrinsic value about 43% below today’s market value, and it scores 3.0 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the STERIS stock price target?
The average 12-month target from 7 analysts is $281.14, 6.4% above the current price of $264.32 Targets range from $244.00 to $305.00.
Is STERIS a buy according to analysts?
The consensus rating is “Buy” (1 strong buy, 5 buy, 2 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is STERIS expected to earn?
Analysts expect EPS of $11.44 for the fiscal year ending March 31, 2027 and $12.46 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.